Fact Sheet: President Donald J. Trump Announces Actions to Reduce Regulatory Barriers to Domestic Pharmaceutical Manufacturing
Fact sheetRegulation easedPublished 25/05/05Open the original
Summary
President Trump orders the FDA to shorten approval of domestic pharmaceutical plants and increase fees for and inspections of foreign plants, and the EPA to accelerate permits for facilities that make drugs and their ingredients.
By industry
- Healthcare & Drug Pricing1 trading day+0.5%p15 stocks5 trading days−4.2%p15 stocks20 trading days−8.7%p15 stocks
“facilitate the restoration of a robust domestic manufacturing base for prescription drugs”
Day by day after the announcement
| Day | Healthcare & Drug Pricing stocks | S&P 500 |
|---|---|---|
| 25/05/02 | 0.0% | 0.0% |
| 25/05/05 | −0.2% | −0.7% |
| 25/05/06 | −2.6% | −0.7% |
| 25/05/07 | −1.9% | −1.0% |
| 25/05/08 | −3.5% | −0.4% |
| 25/05/09 | −4.6% | −0.4% |
| 25/05/12 | −3.4% | +2.9% |
| 25/05/13 | −6.9% | +3.5% |
| 25/05/14 | −9.5% | +3.5% |
| 25/05/15 | −7.4% | +4.2% |
| 25/05/16 | −5.4% | +3.8% |
| 25/05/19 | −4.1% | +4.9% |
| 25/05/20 | −3.5% | +4.5% |
| 25/05/21 | −5.3% | +2.8% |
| 25/05/22 | −6.0% | +2.9% |
| 25/05/23 | −5.9% | +2.1% |
| 25/05/27 | −5.1% | +4.4% |
| 25/05/28 | −5.7% | +5.1% |
| 25/05/29 | −4.9% | +4.0% |
| 25/05/30 | −4.0% | +4.0% |
| 25/06/02 | −4.1% | +4.6% |
Korean stocks in these industries
- Samsung Biologics 207940
- Celltrion 068270
- SK Biopharmaceuticals 326030
Trades in these industries around the announcement
Members' and insiders' trades in the industries' stocks, 30 days before to 30 days after.
- Stephen J. Hemsley
BuyUnitedhealth Group
BuyUnitedhealth Group
UNH
$25M
86,700 sh
$25M
Filed 25/05/16
Traded 25/05/16
- John F. Rex
BuyUnitedhealth Group
BuyUnitedhealth Group
UNH
$5M
17,175 sh
$5M
Filed 25/05/16
Traded 25/05/16
- Kristen Gil
BuyUnitedhealth Group
BuyUnitedhealth Group
UNH
$1M
3,700 sh
$1M
Filed 25/05/16
Traded 25/05/15
- Timothy Patrick Flynn
BuyUnitedhealth Group
BuyUnitedhealth Group
UNH
$491.8K
1,533 sh
$491.8K
Filed 25/05/16
Traded 25/05/14
- John H. Noseworthy
BuyUnitedhealth Group
BuyUnitedhealth Group
UNH
$93.6K
300 sh
$93.6K
Filed 25/05/16
Traded 25/05/14
- Samit Hirawat
BuyBristol Myers Squibb
BuyBristol Myers Squibb
BMY
$202.2K
4,250 sh
$202.2K
Filed 25/04/29
Traded 25/04/25
- Julia Letlow
BuyUnitedhealth Group
BuyUnitedhealth Group
UNH
$1K–$15K
Self
$1K–$15K
Reported 01/13
Traded 25/04/22
- Julia Letlow
Full saleUnitedhealth Group
Full saleUnitedhealth Group
UNH
$1K–$15K
Self
$1K–$15K
Reported 01/13
Traded 25/05/27
- Larry Robbins
SellCVS Health
SellCVS Health
CVS
$113.2M
1,679,736 sh
$113.2M
Filed 25/05/06
Traded 25/05/02
- Larry Robbins
SellCVS Health
SellCVS Health
CVS
$82.7M
1,226,933 sh
$82.7M
Filed 25/05/06
Traded 25/05/05
- Julia Letlow
BuyAbbVie
BuyAbbVie
ABBV
$1K–$15K
Self
$1K–$15K
Reported 01/13
Traded 25/04/28
- Julia Letlow
Full saleCigna Group
Full saleCigna Group
CI
$1K–$15K
Self
$1K–$15K
Reported 01/13
Traded 25/04/22
- John Boozman
BuyUnitedhealth Group
BuyUnitedhealth Group
UNH
$1K–$15K
Joint
$1K–$15K
Reported 25/05/14
Traded 25/04/16
- Larry Robbins
SellCVS Health
SellCVS Health
CVS
$26M
373,776 sh
$26M
Filed 25/05/06
Traded 25/05/02
- Mark Kaye
SellElevance Health
SellElevance Health
ELV
$1.9M
4,588 sh
$1.9M
Filed 25/04/25
Traded 25/04/24
- Larry Robbins
SellCVS Health
SellCVS Health
CVS
$15.2M
222,556 sh
$15.2M
Filed 25/05/06
Traded 25/05/02
- Tommy Tuberville
Full saleELI Lilly
Full saleELI Lilly
LLY
$15K–$50K
Joint
$15K–$50K
Reported 25/05/15
Traded 25/04/15
- Tommy Tuberville
Full saleAmgen
Full saleAmgen
AMGN
$15K–$50K
Joint
$15K–$50K
Reported 25/05/15
Traded 25/04/15
- Larry Robbins
SellCVS Health
SellCVS Health
CVS
$10M
150,000 sh
$10M
Filed 25/05/06
Traded 25/05/06
- Daniel Patrick O'Day
Sell10b5-1 planGilead Sciences
Sell10b5-1 planGilead Sciences
GILD
$706.5K
6,416 sh
$706.5K
Filed 25/06/02
Traded 25/05/30